ISMOTIC Drug Patent Profile
Which patents cover Ismotic, and when can generic versions of Ismotic launch?
Ismotic is a drug marketed by Alcon and is included in one NDA.
The generic ingredient in ISMOTIC is isosorbide. There is one drug master file entry for this compound. Additional details are available on the isosorbide profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ISMOTIC?
- What are the global sales for ISMOTIC?
- What is Average Wholesale Price for ISMOTIC?
Summary for ISMOTIC
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 76 |
| Patent Applications: | 4,227 |
| DailyMed Link: | ISMOTIC at DailyMed |
US Patents and Regulatory Information for ISMOTIC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alcon | ISMOTIC | isosorbide | SOLUTION;ORAL | 017063-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
